Nicole Sweeny - Jan 12, 2023 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Role
Chief Commercial Officer
Signature
/s/ Alex Nemiroff, as Attorney-in-Fact
Stock symbol
PRAX
Transactions as of
Jan 12, 2023
Transactions value $
$0
Form type
4
Date filed
1/17/2023, 06:38 PM
Previous filing
Jan 9, 2023
Next filing
Feb 13, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRAX Stock Option (Right to Buy) Award $0 +120K $0.00 120K Jan 12, 2023 Common Stock 120K $2.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date.